Ashraf I. Amin

916 total citations
12 papers, 755 citations indexed

About

Ashraf I. Amin is a scholar working on Epidemiology, Cancer Research and Pharmacology. According to data from OpenAlex, Ashraf I. Amin has authored 12 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Cancer Research and 3 papers in Pharmacology. Recurrent topics in Ashraf I. Amin's work include Adipokines, Inflammation, and Metabolic Diseases (6 papers), Apelin-related biomedical research (3 papers) and MicroRNA in disease regulation (2 papers). Ashraf I. Amin is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (6 papers), Apelin-related biomedical research (3 papers) and MicroRNA in disease regulation (2 papers). Ashraf I. Amin collaborates with scholars based in Egypt, United Kingdom and Spain. Ashraf I. Amin's co-authors include Hala O. El‐Mesallamy, Dina H. Kassem, Ebtehal El‐Demerdash, Ahmed S. Doghish, Ahmed I. Abulsoud, Hayat M. Sharada, Gyanendra Tripathi, Mohga S. Abdalla, Sudhesh Kumar and Philip G. McTernan and has published in prestigious journals such as Metabolism, The Journal of Nutritional Biochemistry and Diabetes Research and Clinical Practice.

In The Last Decade

Ashraf I. Amin

10 papers receiving 738 citations

Peers

Countries citing papers authored by Ashraf I. Amin

Since Specialization

Citations

This map shows the geographic impact of Ashraf I. Amin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf I. Amin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf I. Amin more than expected).

Fields of papers citing papers by Ashraf I. Amin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf I. Amin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf I. Amin. The network helps show where Ashraf I. Amin may publish in the future.

Co-authorship network of co-authors of Ashraf I. Amin

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf I. Amin. A scholar is included among the top collaborators of Ashraf I. Amin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf I. Amin. Ashraf I. Amin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Circulating miR-148a-5p and miR-21-5p as Novel Diagnostic Biomarkers in Adult Egyptian Male Patients With Metabolic Syndrome 2021 ·Canadian Journal of Diabetes ·Ahmed S. Doghish, (unknown), Ashraf I. Amin, Ahmed I. Abulsoud	73
2	<p>Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients</p> 2019 ·Diabetes Metabolic Syndrome and Obesity ·Mohamed Bakr Zaki, Ahmed I. Abulsoud, (unknown), Ahmed S. Doghish, (unknown), Ashraf I. Amin, Mahmoud A. Elrebehy, (unknown), (unknown)	74
3	The (FTO) gene polymorphism is associated with metabolic syndrome risk in Egyptian females: a case- control study 2017 ·BMC Medical Genetics ·(unknown), Nadia Μ. Hamdy, Ashraf I. Amin, Hala O. El‐Mesallamy	38
4	Genotype screening of APLN rs3115757 variant in Egyptian women population reveals an association with obesity and insulin resistance 2015 ·Diabetes Research and Clinical Practice ·(unknown), Nadia Μ. Hamdy, Ashraf I. Amin, Hala O. El‐Mesallamy	22
5	The Serine Protease Granzyme B as an Inflammatory Marker, in Relation to the Insulin Receptor Cleavage in Human Obesity and Type 2 Diabetes Mellitus 2013 ·Journal of Interferon & Cytokine Research ·Hala O. El‐Mesallamy, Nadia Μ. Hamdy, (unknown), Ashraf I. Amin	35
6	Changes of serum omentin-1 levels and relationship between omentin-1 and insulin resistance in chronic hepatitis C patients 2013 ·PubMed ·(unknown), Ashraf I. Amin, (unknown), Dalia H. Abdelaziz	14
7	Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro 2011 ·The Journal of Nutritional Biochemistry ·(unknown), Kirsty McGee, Gyanendra Tripathi, Nasser M. Al‐Daghri, Mohga S. Abdalla, Hayat M. Sharada, Esmat Ashour, Ashraf I. Amin, Antonio Ceriello, Joseph Paul O’Hare, Sudhesh Kumar, Philip G. McTernan, Alison L. Harte	53
8	The interplay of YKL-40 and leptin in type 2 diabetic obese patients 2011 ·Diabetes Research and Clinical Practice ·Hala O. El‐Mesallamy, (unknown), Ashraf I. Amin, (unknown)	11
9	Elevated endotoxin levels in non-alcoholic fatty liver disease 2010 ·Journal of Inflammation ·Alison L. Harte, Nancy F. da Silva, S. J. Creely, Kirsty McGee, (unknown), (unknown), Gyanendra Tripathi, Esmat Ashour, Mohga S. Abdalla, Hayat M. Sharada, Ashraf I. Amin, Alastair D. Burt, Sudhesh Kumar, Christopher P. Day, Philip G. McTernan	316
10	Association of serum Leptin and Adiponectin with Atherosclerosis in obese and non-obese Type 2 Diabetes Mellitus patients 2010 ·Mohga S. Abdalla, Hayat M. Sharada, Ashraf I. Amin, (unknown), (unknown), Esmat Ashour, (unknown)	1
11	Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus 2010 ·Metabolism ·Hala O. El‐Mesallamy, Dina H. Kassem, Ebtehal El‐Demerdash, Ashraf I. Amin	118
12	Growth Hormone/Insulin Growth Factor-1 and Growth in IDDM Children and Adolescents. 2000 ·Journal of Clinical Biochemistry and Nutrition ·(unknown), (unknown), (unknown), (unknown), Ashraf I. Amin	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact